课题基金 / 基金详情

Basic research on antlangiogenic drug to prevent metastasls of gastric cancer

Basic research on antlangiogenic drug to prevent metastasls of gastric cancer
抗血管生成药物预防胃癌转移的基础研究
批准号:
14571207
负责人:
KAKEJI Yoshihiro
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

KAKEJI Yoshihiro的其他基金

相关文献

中文摘要
翻译
为探讨缺氧诱导因子(HIF)-1α和p53表达对人胃癌预后的影响,分析肿瘤的临床病理特征及临床转归。采用免疫组化方法研究了216例原发性胃癌标本中HIF-1α和p53蛋白的表达。HIF-1α (+)/p53(+)肿瘤较HIE-1α (-) /p53(-)肿瘤多为未分化型、浸润性生长、浸润性淋巴累及。HIF-1α (+)/p53(+)肿瘤的淋巴结转移率高于HIF-1α (+)/p53(+)肿瘤。在HIF-1α和p53阳性分层时,p53阴性和HIF-1α阴性患者预后最好,p53阳性和HIF-1α阳性患者预后最差(P=0.0018)。多因素Cox回归分析显示,浸润深度、淋巴结转移、HIF-1α阳性是影响胃癌患者预后的独立因素。HIF-1α是胃癌的独立预后因素之一,HIF-1α蛋白过表达与无功能p53的结合预示着胃癌预后较差。
英文摘要
To investigate the impact of expression of hypoxia-inducible factor (HIF)-1α and p53 on prognosis in human gastric cancer, the clinicopathological characteristics of tumor and clinical outcome were analyzed. Expression of HIF-1α and p53 proteins were studied by immunohistochemistry in 216 specimens of primary gastric cancer. HIF-1α (+)/p53(+) tumors were more frequently undifferentiated type, infiltrative growth appearance, invasive in lymphatic involvement than could be the HIE-1α (-)1p53(-) ones. HIF-1α (+)/p53(+) tumors also had more lymph node metastasis than did HIF-1α (+)/p53(+) ones. When stratified for HIF-1α and p53 positivity, the patients with p53-negative and HIF-1α -negative had the most favorable prognosis and those with p53-positive and HIF-1α -positive had the worst one (P=0.0018). Using multivariate Cox regression analysis, depth of invasion, lymph node metastasis, and HIF-1α positivity were independent prognostic factors in the patients with gastric cancer. HIF-1α is one of the independent prognostic factors in gastric cancer, and the combination of HIF-1α protein overexpression with nonfunctional p53 indicates a dismal prognosis.
期刊论文(85)
专著(0)
科研奖励(0)
会议论文
Maehara Y, et al.: "Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer."Surgery. 131・1 Suppl S. S85-S91 (2002)
Maehara Y 等人:“胃癌患者的淋巴结清扫术的治疗价值和临床结果”。Surgery 131・1 Suppl S. S85-S91 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takahashi I, Emi Y, Hasuda S, Kakeji Y, Maehara Y, Suginiachi K: "Clinical application of hyperthermia combined with anticancer drugs for the treatment of solid tumors."Surgery. 131(1 Suppl S). S78-S84 (2002)
Takahashi I、Emi Y、Hasuda S、Kakeji Y、Maehara Y、Suginiachi K:“热疗联合抗癌药物治疗实体瘤的临床应用。”外科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kakeji Y, et al.: "Angiogenesis as a target for gastric cancer."Surgery. 131・1 Suppl S. S48-S54 (2002)
Kakeji Y 等人:“血管生成作为胃癌的靶标。”Surgery 131・1 Suppl S.S48-S54 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ohga T, Tanaka S, Maehara S, Futatsugi M, Ito S, Kiniura Y, Saeki H, Kakeji Y, Maehara Y: "Development of DNA microarray system-From Bench to Bed in Esophageal Cancers."Cytometry Research. 12(2). 121-129 (2002)
Ohga T、Tanaka S、Maehara S、Futatsugi M、Ito S、Kiniura Y、Saeki H、Kakeji Y、Maehara Y:“DNA 微阵列系统的开发 - 从食管癌的工作台到床上。”细胞计数研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
29
    The development of the high precision navigation system of sentinel node in gastrointestinal cancer in an open MRI operating theater
    • 批准号:
      24650298
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      KAKEJI Yoshihiro
    • 依托单位:
    The Y-box binding protein-1 (YB-1) functions in various biological processes, including transcriptional and translational control, DNA repair, drug resistance, and cell proliferation in gastrointestinal malignancies.
    • 批准号:
      20591548
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      KAKEJI Yoshihiro
    • 依托单位:
    Intraoperative 3-D image acquisition and augmented reality for laparoscopic/thoracoscopic surgical navigation system
    • 批准号:
      16300172
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.93万
    • 财政年份:
      2004
    • 负责人:
      KAKEJI Yoshihiro
    • 依托单位: